| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J9271 |
Injection, pembrolizumab, 1 mg |
140 |
108 |
$815K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,527 |
2,570 |
$596K |
| J0897 |
Injection, denosumab, 1 mg |
417 |
391 |
$306K |
| J9355 |
Injection, trastuzumab, excludes biosimilar, 10 mg |
171 |
102 |
$267K |
| 96367 |
|
3,655 |
2,176 |
$174K |
| Q5108 |
Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg |
179 |
115 |
$166K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,561 |
5,587 |
$154K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
6,698 |
3,634 |
$130K |
| J2505 |
Injection, pegfilgrastim, 6 mg |
219 |
140 |
$123K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
5,023 |
2,859 |
$96K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
4,700 |
2,348 |
$60K |
| J7050 |
Infusion, normal saline solution, 250 cc |
5,835 |
3,530 |
$56K |
| 99215 |
Prolong outpt/office vis |
1,720 |
1,472 |
$54K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
386 |
284 |
$51K |
| J1453 |
Injection, fosaprepitant, 1 mg |
1,792 |
1,103 |
$44K |
| 96417 |
|
2,193 |
1,311 |
$22K |
| 96368 |
|
1,579 |
976 |
$22K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,248 |
2,247 |
$21K |
| Q5111 |
Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg |
33 |
25 |
$18K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
766 |
413 |
$10K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,994 |
1,202 |
$7K |
| 96415 |
|
1,044 |
691 |
$7K |
| 96411 |
|
1,124 |
702 |
$7K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
423 |
198 |
$6K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
371 |
325 |
$5K |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
75 |
39 |
$4K |
| J9190 |
Injection, fluorouracil, 500 mg |
535 |
273 |
$3K |
| 96416 |
|
111 |
51 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
594 |
470 |
$2K |
| J0641 |
Injection, levoleucovorin, not otherwise specified, 0.5 mg |
150 |
76 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
830 |
535 |
$1K |
| J9045 |
Injection, carboplatin, 50 mg |
76 |
52 |
$1K |
| 80053 |
Comprehensive metabolic panel |
417 |
300 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
1,835 |
1,219 |
$1K |
| J3489 |
Injection, zoledronic acid, 1 mg |
15 |
13 |
$372.78 |
| J9000 |
Injection, doxorubicin hydrochloride, 10 mg |
43 |
24 |
$370.72 |
| J1626 |
Injection, granisetron hydrochloride, 100 mcg |
71 |
31 |
$174.72 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
130 |
87 |
$69.81 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
17 |
13 |
$54.02 |
| 83735 |
|
38 |
31 |
$0.00 |